- Home
- FOF vs AMLX Comparison
FOF vs AMLX Comparison
Compare FOF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOF
- AMLX
- Stock Information
- Founded
- FOF 2006
- AMLX 2014
- Country
- FOF United States
- AMLX United States
- Employees
- FOF N/A
- AMLX N/A
- Industry
- FOF Investment Managers
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- FOF Finance
- AMLX Health Care
- Exchange
- FOF Nasdaq
- AMLX Nasdaq
- Market Cap
- FOF 341.7M
- AMLX 330.5M
- IPO Year
- FOF N/A
- AMLX 2022
- Fundamental
- Price
- FOF $11.35
- AMLX $3.98
- Analyst Decision
- FOF
- AMLX Buy
- Analyst Count
- FOF 0
- AMLX 4
- Target Price
- FOF N/A
- AMLX $8.50
- AVG Volume (30 Days)
- FOF 58.7K
- AMLX 810.7K
- Earning Date
- FOF 01-01-0001
- AMLX 05-08-2025
- Dividend Yield
- FOF 9.07%
- AMLX N/A
- EPS Growth
- FOF N/A
- AMLX N/A
- EPS
- FOF N/A
- AMLX N/A
- Revenue
- FOF N/A
- AMLX $87,371,000.00
- Revenue This Year
- FOF N/A
- AMLX N/A
- Revenue Next Year
- FOF N/A
- AMLX N/A
- P/E Ratio
- FOF N/A
- AMLX N/A
- Revenue Growth
- FOF N/A
- AMLX N/A
- 52 Week Low
- FOF $9.59
- AMLX $1.58
- 52 Week High
- FOF $11.75
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- FOF 44.24
- AMLX 59.35
- Support Level
- FOF $11.17
- AMLX $3.79
- Resistance Level
- FOF $11.54
- AMLX $4.05
- Average True Range (ATR)
- FOF 0.48
- AMLX 0.32
- MACD
- FOF 0.00
- AMLX 0.04
- Stochastic Oscillator
- FOF 52.13
- AMLX 86.14
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.